EDWARDS LIFESCIENCES CORP (1EW.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1EW - US28176E1082 - Common Stock
73.47 EUR
+6.99 (+10.51%)
1EW gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 62 industry peers in the Health Care Equipment & Supplies industry. 1EW has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1EW is quite expensive at the moment. It does show a decent growth rate. With these ratings, 1EW could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
1EW had positive earnings in the past year.
1EW had a positive operating cash flow in the past year.
In the past 5 years 1EW has always been profitable.
1EW had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 10.31%, 1EW belongs to the top of the industry, outperforming 90.16% of the companies in the same industry.
With a decent Return On Equity value of 13.40%, 1EW is doing good in the industry, outperforming 78.69% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 12.50%, 1EW belongs to the top of the industry, outperforming 88.52% of the companies in the same industry.
1EW had an Average Return On Invested Capital over the past 3 years of 15.82%. This is significantly above the industry average of 9.74%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 12.5% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
1.3 Margins
The Profit Margin of 1EW (23.25%) is better than 93.44% of its industry peers.
1EW's Profit Margin has improved in the last couple of years.
1EW has a better Operating Margin (27.73%) than 98.36% of its industry peers.
In the last couple of years the Operating Margin of 1EW has remained more or less at the same level.
Looking at the Gross Margin, with a value of 78.19%, 1EW belongs to the top of the industry, outperforming 91.80% of the companies in the same industry.
In the last couple of years the Gross Margin of 1EW has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
1EW has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, 1EW has less shares outstanding
Compared to 5 years ago, 1EW has less shares outstanding
The debt/assets ratio for 1EW has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 12.38 indicates that 1EW is not in any danger for bankruptcy at the moment.
1EW has a Altman-Z score of 12.38. This is amongst the best in the industry. 1EW outperforms 95.08% of its industry peers.
The Debt to FCF ratio of 1EW is 0.75, which is an excellent value as it means it would take 1EW, only 0.75 years of fcf income to pay off all of its debts.
1EW has a better Debt to FCF ratio (0.75) than 93.44% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that 1EW is not too dependend on debt financing.
1EW has a better Debt to Equity ratio (0.06) than 86.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 12.38 |
ROIC/WACC1.45
WACC8.62%
2.3 Liquidity
A Current Ratio of 4.00 indicates that 1EW has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.00, 1EW belongs to the top of the industry, outperforming 91.80% of the companies in the same industry.
1EW has a Quick Ratio of 3.29. This indicates that 1EW is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.29, 1EW belongs to the best of the industry, outperforming 91.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
1EW shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.75%.
Measured over the past 5 years, 1EW shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
1EW shows a small growth in Revenue. In the last year, the Revenue has grown by 4.67%.
The Revenue has been growing slightly by 4.58% on average over the past years.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
3.2 Future
The Earnings Per Share is expected to grow by 9.50% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.55% on average over the next years. This is quite good.
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 32.95, 1EW can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as 1EW.
1EW's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.77.
1EW is valuated quite expensively with a Price/Forward Earnings ratio of 28.93.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1EW is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.35. 1EW is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.95 | ||
| Fwd PE | 28.93 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1EW indicates a slightly more expensive valuation: 1EW is more expensive than 60.66% of the companies listed in the same industry.
1EW's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 61.42 | ||
| EV/EBITDA | 25.01 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1EW does not grow enough to justify the current Price/Earnings ratio.
1EW has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)77.74
PEG (5Y)4.62
EPS Next 2Y5.67%
EPS Next 3Y7.57%
5. Dividend
5.1 Amount
No dividends for 1EW!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1EW (11/11/2025, 7:00:00 PM)
73.47
+6.99 (+10.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap42.63B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts77.67
Price Target81.34 (10.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-4.64%
Revenue beat(12)2
Avg Revenue beat(12)-3.41%
Revenue beat(16)2
Avg Revenue beat(16)-3.45%
PT rev (1m)5.02%
PT rev (3m)5.02%
EPS NQ rev (1m)-1.51%
EPS NQ rev (3m)-1.51%
EPS NY rev (1m)4.19%
EPS NY rev (3m)4.19%
Revenue NQ rev (1m)2.72%
Revenue NQ rev (3m)2.72%
Revenue NY rev (1m)3.45%
Revenue NY rev (3m)3.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.95 | ||
| Fwd PE | 28.93 | ||
| P/S | 8.35 | ||
| P/FCF | 61.42 | ||
| P/OCF | 48.3 | ||
| P/B | 4.81 | ||
| P/tB | 6.72 | ||
| EV/EBITDA | 25.01 |
EPS(TTM)2.23
EY3.04%
EPS(NY)2.54
Fwd EY3.46%
FCF(TTM)1.2
FCFY1.63%
OCF(TTM)1.52
OCFY2.07%
SpS8.8
BVpS15.27
TBVpS10.93
PEG (NY)77.74
PEG (5Y)4.62
Graham Number27.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 12.5% | ||
| ROICexc | 18.63% | ||
| ROICexgc | 29.56% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
ROICexc(3y)20.51%
ROICexc(5y)22.13%
ROICexgc(3y)29.09%
ROICexgc(5y)31.03%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 12.38 |
F-Score6
WACC8.62%
ROIC/WACC1.45
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.47%
EBIT Next 3Y11.73%
EBIT Next 5Y12.76%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%
EDWARDS LIFESCIENCES CORP / 1EW.MI FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 7 / 10 to 1EW.MI.
What is the valuation status for 1EW stock?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (1EW.MI). This can be considered as Overvalued.
How profitable is EDWARDS LIFESCIENCES CORP (1EW.MI) stock?
EDWARDS LIFESCIENCES CORP (1EW.MI) has a profitability rating of 8 / 10.
Can you provide the expected EPS growth for 1EW stock?
The Earnings per Share (EPS) of EDWARDS LIFESCIENCES CORP (1EW.MI) is expected to grow by 0.42% in the next year.